211-225 of 847
From Diagnosis to Treatment: Challenges in Glioblastoma Care
NeuroFrontiersFrom Diagnosis to Treatment: Challenges in Glioblastoma Care
Lauren Schaff, MD
Vorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
NeuroFrontiersVorasidenib and mIDH Gliomas: Reviewing the Efficacy Data
Jennie Taylor, MD
Decoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
On the Frontlines of CIDPDecoding CIDP: Pathogenesis, Diagnosis, and Clinical Clues
Hans Katzberg, MD
Genetics in Schizophrenia Management: Emerging Technological Strategies
On the Frontlines of SchizophreniaGenetics in Schizophrenia Management: Emerging Technological Strategies
Aaron Besterman, MD
Understanding CIDP: A Roadmap to Diagnosis
On the Frontlines of CIDPUnderstanding CIDP: A Roadmap to Diagnosis
Sami Khella, MD
Evolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
On the Frontlines of CIDPEvolving Strategies in CIDP Care: Personalized Approaches and Emerging Treatments
Sami Khella, MD
- advertisement
Investigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
NeuroFrontiersInvestigating Gene Therapy for DMD: The Role of Caregiver-Reporter Scales
Craig M. McDonald, MD
Next Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
NeuroFrontiersNext Steps in Gene Therapy Research for Duchenne Muscular Dystrophy
Craig M. McDonald, MD
Monitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
NeuroFrontiersMonitoring Multiple Sclerosis: The Role of Serum Neurofilament Light Chain Levels
Engineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
NeuroFrontiersEngineering Autoimmunity: A New Model for Studying MS Progression and Remyelination
Christian Cordano, MD, PhD
Advances in MS Management: Current and Future Directions
NeuroFrontiersAdvances in MS Management: Current and Future Directions
Diagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
NeuroFrontiersDiagnosing Duchenne Muscular Dystrophy: Recognizing Signs and Reducing Delays
Nancy Kuntz, MD
- advertisement
Duchenne Muscular Dystrophy Management: Analyzing Current Approaches
NeuroFrontiersDuchenne Muscular Dystrophy Management: Analyzing Current Approaches
Nancy Kuntz, MD
From Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
NeuroFrontiersFrom Trials to Practice: Evaluating Xanomeline-Trospium Chloride for Schizophrenia
Ashley Baker, MSN, PMHNP
Steven Paul, MD
Exploring Metabolomics in Multiple Sclerosis
NeuroFrontiersExploring Metabolomics in Multiple Sclerosis
Pavan Barghava, MD
